Abstract
Background: Several pharmacological therapeutic interventions are being used as therapeutic agentsagainst myocardial infarction/ischemia (MI) but their usage is constrained by toxicity and nonselective pharmacologicalactions. Our preliminary report depicted the cardioprotective effect of piperine against isoproterenol(ISO)-induced MI.
Aim: Current study determined the protective efficacy of piperine by modulating mitochondrial function in ratmodels of isoproterenol (ISO)-induced myocardial ischemia.
Methods: The above aim was achieved by analyzing mitochondrial antioxidant status, mitochondrial calcium,mitochondrial enzyme activity, ATP level, and apoptosis. Ultra-structural alterations in heart tissue were determinedby TEM analysis. RT-PCR studies and Western blotting were executed to determine apoptotic andproapoptotic gene expression, and apoptotic protein expression, respectively.
Results: The results elucidate that piperine pre-treatment prevents ISO induced alterations in the mitochondrialantioxidant status, Krebs cycle as well as mitochondrial respiratory chain enzyme activities (MRCEs). ISO inducedultrastructural changes of heart mitochondria were significantly reduced in the group that receivedpiperine pretreatment followed by ISO injection. Piperine maintains mitochondrial calcium homeostasis and inhibitsISO-induced myocardial apoptosis. A significant increase in the expression levels of proapoptotic genessuch as Bax, caspases (caspase 9, caspase 3), and cytochrome-c with a concomitant decrease in Bcl-2 expression(anti-apoptotic gene) was observed in ISO injected group compared to the control group. The group that receivedthe piperine pretreatment followed by ISO administration showed a significant decrease in the expressionprofile of proapoptotic genes with a concomitant increase in the anti-apoptotic gene expression than theISO injected group. Apoptotic protein expressions including Bax, cytochrome-c, caspase-3, and cleaved PARPwere upregulated & Bcl-2 was downregulated with ISO treatment, whereas piperine pre-treatment prevented thesechanges in apoptotic protein expressions during ISO-induced myocardial cell damage.
Conclusion: Current results demonstrate the efficacy of piperine for attenuating ISO-induced myocardial ischemiaby enhancing mitochondria function. This study described that piperine could be used as a nutritional interventionagainst ISO-induced myocardial ischemia.
Keywords:Myocardial infarction, piperine, isoproterenol, mitochondria, ATP, apoptosis.
Current Pharmaceutical Design
Title:The Role of Mitochondria in Piperine Mediated Cardioprotection in Isoproterenol Induced Myocardial Ischemia
Volume: 27Issue: 26
Author(s):Vijaya Padma Viswanadha*, Velumani Dhivya, Bharath Somasundaram, Narasimha Murthy Beeraka, Chih-Yang Huang, Liudmila M. Mikhaleva, Evgeny Achkasov, Sergey Bondarev, Leonid Gridin, Vladimir N. Nikolenko and Gjumrakch Aliev*
Affiliation:
- Translational Research Laboratory, Department of Biotechnology, Bharathiar University, Coimbatore-641046, Tamil Nadu,India
- I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), St. Trubetskaya, 8, bld. 2, Moscow, 119991,Russian Federation
Keywords:Myocardial infarction, piperine, isoproterenol, mitochondria, ATP, apoptosis.
Abstract:
Background: Several pharmacological therapeutic interventions are being used as therapeutic agentsagainst myocardial infarction/ischemia (MI) but their usage is constrained by toxicity and nonselective pharmacologicalactions. Our preliminary report depicted the cardioprotective effect of piperine against isoproterenol(ISO)-induced MI.
Aim: Current study determined the protective efficacy of piperine by modulating mitochondrial function in ratmodels of isoproterenol (ISO)-induced myocardial ischemia.
Methods: The above aim was achieved by analyzing mitochondrial antioxidant status, mitochondrial calcium,mitochondrial enzyme activity, ATP level, and apoptosis. Ultra-structural alterations in heart tissue were determinedby TEM analysis. RT-PCR studies and Western blotting were executed to determine apoptotic andproapoptotic gene expression, and apoptotic protein expression, respectively.
Results: The results elucidate that piperine pre-treatment prevents ISO induced alterations in the mitochondrialantioxidant status, Krebs cycle as well as mitochondrial respiratory chain enzyme activities (MRCEs). ISO inducedultrastructural changes of heart mitochondria were significantly reduced in the group that receivedpiperine pretreatment followed by ISO injection. Piperine maintains mitochondrial calcium homeostasis and inhibitsISO-induced myocardial apoptosis. A significant increase in the expression levels of proapoptotic genessuch as Bax, caspases (caspase 9, caspase 3), and cytochrome-c with a concomitant decrease in Bcl-2 expression(anti-apoptotic gene) was observed in ISO injected group compared to the control group. The group that receivedthe piperine pretreatment followed by ISO administration showed a significant decrease in the expressionprofile of proapoptotic genes with a concomitant increase in the anti-apoptotic gene expression than theISO injected group. Apoptotic protein expressions including Bax, cytochrome-c, caspase-3, and cleaved PARPwere upregulated & Bcl-2 was downregulated with ISO treatment, whereas piperine pre-treatment prevented thesechanges in apoptotic protein expressions during ISO-induced myocardial cell damage.
Conclusion: Current results demonstrate the efficacy of piperine for attenuating ISO-induced myocardial ischemiaby enhancing mitochondria function. This study described that piperine could be used as a nutritional interventionagainst ISO-induced myocardial ischemia.
Export Options
About this article
Cite this article as:
Viswanadha Padma Vijaya *, Dhivya Velumani, Somasundaram Bharath , Beeraka Murthy Narasimha , Huang Chih-Yang , Mikhaleva M. Liudmila , Achkasov Evgeny , Bondarev Sergey , Gridin Leonid , Nikolenko N. Vladimir and Aliev Gjumrakch *, The Role of Mitochondria in Piperine Mediated Cardioprotection in Isoproterenol Induced Myocardial Ischemia, Current Pharmaceutical Design 2021; 27 (26) .https://dx.doi.org/10.2174/1381612826666200909125750
DOI https://dx.doi.org/10.2174/1381612826666200909125750 | Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher | Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
Advances in the Molecular Pathogenesis of Inflammatory Bowel Disease.
This thematic issue will emphasize the recent breakthroughs in the mechanisms of Inflammatory bowel disease (IBD) pathogenesis and devotes some understanding of both Crohn’s and ulcerative colitis. It is expected to include studies about cellular and genetic aspects, which help to precipitate the disease, and the immune system-gut microbiome relations ...read more
Blood-based biomarkers in large-scale screening for neurodegenerative diseases
Disease biomarkers are necessary tools that can be employed in several clinical context of use (COU), ranging from the (early) diagnosis, prognosis, and prediction, to monitoring of disease state and/or drug efficacy. Regarding neurodegenerative diseases, in particular Alzheimer’s disease (AD), a battery of well-validated biomarkers are available, such as cerebrospinal ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Diabetes mellitus: advances in diagnosis and treatment driving by precision medicine
Diabetes mellitus (DM) is a chronic degenerative metabolic disease with ever increasing prevalence worldwide which is now an epidemic disease affecting 500 million people worldwide. Insufficient insulin secretion from pancreatic β cells unable to maintain blood glucose homeostasis is the main feature of this disease. Multifactorial and complex nature of ...read more

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
- Vitamin D: A Regulator of Metabolism and Inflammation
Current Nutrition & Food ScienceCardiovascular Disease Burden and Risk Factors Before and After Kidney Transplant
Cardiovascular & Hematological Disorders-Drug TargetsA Hypothesis for Regenerative Therapy for Neuronal Disease: Stem Cells within Artificial Niche
Current Signal Transduction TherapyInducible Nitric Oxide Synthase Expression is a Potential Marker for Acute Coronary Syndrome: A Preliminary Study
Current Biomarkers (Discontinued)Parkinson's Disease, Diabetes and Cognitive Impairment
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)Update on Cancer Related Issues of Mesenchymal Stem Cell-Based Therapies
Current Stem Cell Research & TherapyMetaflammation: Tissue-Specific Alterations of the NLRP3 Inflammasome Platform in Metabolic Syndrome
Current Medicinal Chemistry Endothelial Dysfunction and Coronary Artery Spasm
Current Drug Targets - Cardiovascular & Hematological DisordersThe ATP-dependent Pathways and Human Diseases
Current Medicinal Chemistry Anesthetic Considerations for Electroconvulsive Therapy-Especially Hemodynamic and Respiratory Management
Current Psychiatry ReviewsGlycaemic Control in Cardiac Surgery Patients: a Double-Edged Sword
Current Vascular Pharmacology Application of Transcranial Color-Coded Duplex Sonography in Stroke Diagnosis
Current Medical ImagingRadiolabeled Peptides for Molecular Imaging of Apoptosis
Current Medicinal Chemistry PUFA for Human Health: Diet or Supplementation?
Current Pharmaceutical DesignCombinatorial Therapies for Cardiac Regeneration
Recent Patents on Regenerative MedicineBridging the Gap: The Potential Role of Corticosteroid Binding Globulin in Cardiac Steroid Facilitation
Current Drug TargetsEvaluation and Management of Asymptomatic Bradyarrhythmias
Current Cardiology ReviewsVEGF Signaling Regulates Cofilin and the Arp2/3-complex within the Axonal Growth Cone
Current Neurovascular ResearchDisorders of Consciousness and Electrophysiological Treatment Strategies: A Review of the Literature and New Perspectives
Current Pharmaceutical DesignCurrent and Future Prospective of a Versatile Moiety: Imidazole
Current Drug Targets
[8]ページ先頭